Myriad Genetics reported $127.1M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Accelerate Diagnostics AXDX:US 11.49M 820K
Agilent A:US $ 412M 26M
Becton, Dickinson and BDX:US $ 1.15B 83M
Bio Rad Laboratories BIO:US $ 208.73M 11.34M
Biocept BIOC:US $ 10.47M 5.22M
Bruker BRKR:US $ 152.2M 6.1M
Danaher DHR:US $ 2.08B 7M
Exact Sciences EXAS:US $ 397.59M 4.36M
Fluidigm FLDM:US $ 30.38M 491K
Hologic HOLX:US $ 244.2M 27.7M
Illumina ILMN:US $ 410M 102M
Johnson & Johnson JNJ:US $ 6.23B 288M
Mettler Toledo International MTD:US $ 242.21M 6.89M
Myriad Genetics MYGN:US $ 127.1M 16.5M
Nanostring Technologies NSTG:US $ 36.11M 243K
Orasure Technologies OSUR:US $ 29.26M 2.61M
Pacific Biosciences Of California PACB:US $ 39.25M 552K
Perkinelmer PKI:US $ 330.02M 16.13M
Quest Diagnostics DGX:US $ 422M 6M
Repligen RGEN:US $ 54.65M 349K
Thermo Fisher Scientific TMO:US $ 1.74B 537M
Veracyte VCYT:US $ 39.96M 4.18M
Waters WAT:US $ 161.88M 4.4M